Comino Natalia, Cifuente Javier O, Marina Alberto, Orrantia Ane, Eguskiza Ander, Guerin Marcelo E
From the Structural Biology Unit, CIC bioGUNE, Bizkaia Technology Park, 48160 Derio, Spain.
From the Structural Biology Unit, CIC bioGUNE, Bizkaia Technology Park, 48160 Derio, Spain,
J Biol Chem. 2017 Apr 14;292(15):6255-6268. doi: 10.1074/jbc.M116.773408. Epub 2017 Feb 21.
ADP-glucose pyrophosphorylase (AGPase) controls bacterial glycogen and plant starch biosynthetic pathways, the most common carbon storage polysaccharides in nature. AGPase activity is allosterically regulated by a series of metabolites in the energetic flux within the cell. Very recently, we reported the first crystal structures of the paradigmatic AGPase from (AGPase) in complex with its preferred physiological negative and positive allosteric regulators, adenosine 5'-monophosphate (AMP) and fructose 1,6-bisphosphate (FBP), respectively. However, understanding the molecular mechanism by which AMP and FBP allosterically modulates AGPase enzymatic activity still remains enigmatic. Here we found that single point mutations of key residues in the AMP-binding site decrease its inhibitory effect but also clearly abolish the overall AMP-mediated stabilization effect in wild-type AGPase. Single point mutations of key residues for FBP binding did not revert the AMP-mediated stabilization. Strikingly, an AGPase-R130A mutant displayed a dramatic increase in activity when compared with wild-type AGPase, and this increase correlated with a significant increment of glycogen content The crystal structure of AGPase-R130A revealed unprecedented conformational changes in structural elements involved in the allosteric signal transmission. Altogether, we propose a model in which the positive and negative energy reporters regulate AGPase catalytic activity via intra- and interprotomer cross-talk, with a "sensory motif" and two loops, RL1 and RL2, flanking the ATP-binding site playing a significant role. The information reported herein provides exciting possibilities for industrial/biotechnological applications.
ADP - 葡萄糖焦磷酸化酶(AGPase)控制着细菌糖原和植物淀粉的生物合成途径,这是自然界中最常见的碳储存多糖。AGPase活性受到细胞内能量通量中一系列代谢物的变构调节。最近,我们报道了来自[具体来源未提及]的典型AGPase与其首选的生理性负性和正性变构调节剂,即分别为5'-单磷酸腺苷(AMP)和1,6-二磷酸果糖(FBP)形成复合物的首个晶体结构。然而,理解AMP和FBP变构调节AGPase酶活性的分子机制仍然是个谜。在这里,我们发现AMP结合位点关键残基的单点突变降低了其抑制作用,但也明显消除了野生型AGPase中整体AMP介导的稳定作用。FBP结合关键残基的单点突变并未恢复AMP介导的稳定作用。引人注目的是,与野生型AGPase相比,AGPase - R130A突变体的活性显著增加,并且这种增加与糖原含量的显著增加相关。AGPase - R130A的晶体结构揭示了变构信号传递所涉及的结构元件中前所未有的构象变化。总之,我们提出了一个模型,其中正性和负性能量报告分子通过原聚体内和原聚体间的相互作用调节AGPase催化活性,位于ATP结合位点两侧的“传感基序”以及两个环RL1和RL2发挥着重要作用。本文报道的信息为工业/生物技术应用提供了令人兴奋的可能性。